Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

MEDI

Medimmune (MEDI)

Medimmune (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MEDI
DateTimeSourceHeadlineSymbolCompany
02/08/201017:20Dow Jones NewsPhilips Buys Health Business In Israel, No Financial DetailsNASDAQ:MEDIMedtechnica Ltd.
19/06/200707:37PR Newswire (US)MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% ConvNASDAQ:MEDI
13/06/200704:00PR Newswire (US)MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)NASDAQ:MEDI
26/05/200708:00PR Newswire (US)MedImmune Receives Correspondence From FDA Regarding FluMist(R)NASDAQ:MEDIMedimmune (MM)
25/05/200702:30PR Newswire (US)MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data PresentationsNASDAQ:MEDIMedimmune (MM)
25/05/200702:30PR Newswire (US)Anti-Interleukin-9 Data Presented at the American Thoracic Society MeetingNASDAQ:MEDIMedimmune (MM)
17/05/200706:17PR Newswire (US)FDA Advisory Committee Recommends Expanded Use of FluMist(R)NASDAQ:MEDIMedimmune (MM)
09/05/200705:30PR Newswire (US)Data Show FluMist(R) May Reduce Seasonal Influenza Burden Among Children in School, Daycare SettingsNASDAQ:MEDIMedimmune (MM)
09/05/200703:01PR Newswire (US)MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV DiNASDAQ:MEDIMedimmune (MM)
08/05/200701:25PR Newswire (US)MedImmune Provides Fellowship Grants To Six Pediatric Respiratory ResearchersNASDAQ:MEDIMedimmune (MM)
08/05/200701:14PR Newswire (US)MedImmune Provides Fellowship Grants To Six Pediatric Respiratory ResearchersNASDAQ:MEDIMedimmune (MM)
08/05/200701:05PR Newswire (US)MedImmune Provides Fellowship Grants To Six Pediatric Respiratory ResearchersNASDAQ:MEDIMedimmune (MM)
08/05/200701:00PR Newswire (US)MedImmune Provides Fellowship Grants To Six Pediatric Respiratory ResearchersNASDAQ:MEDIMedimmune (MM)
08/05/200701:00PR Newswire (US)MedImmune Provides Fellowship Grants to Six Pediatric Respiratory ResearchersNASDAQ:MEDIMedimmune (MM)
08/05/200701:00PR Newswire (US)MedImmune Provides Fellowship Grants To Six Pediatric Respiratory ResearchersNASDAQ:MEDIMedimmune (MM)
08/05/200700:30PR Newswire (US)MedImmune and Pediatric Infectious Diseases Society Present 2007 Career Development Award and Viral Respiratory Disease FellowshNASDAQ:MEDIMedimmune (MM)
03/05/200706:31PR Newswire (US)MedImmune, Inc. Announces Convertibility of 1.375% Convertible Senior Notes Due 2011 and 1.625% Convertible Senior Notes Due 201NASDAQ:MEDIMedimmune (MM)
02/05/200723:15PR Newswire (US)Pediatric Academic Societies' Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza,NASDAQ:MEDIMedimmune (MM)
01/05/200708:30PR Newswire (US)MedImmune Reports Financial Results for 2007 First QuarterNASDAQ:MEDIMedimmune (MM)
19/04/200722:30PR Newswire (US)MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE(R) MoleculeNASDAQ:MEDIMedimmune (MM)
19/04/200707:00PR Newswire (US)MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune DiseasesNASDAQ:MEDIMedimmune (MM)
19/04/200703:05PR Newswire (US)Micromet and MedImmune Present Data From Preclinical Study of New BiTE(R) Molecule Targeting CEANASDAQ:MEDIMedimmune (MM)
17/04/200700:45PR Newswire (US)Icahn Comments on MedImmune Sale ProcessNASDAQ:MEDIMedimmune (MM)
12/04/200723:38PR Newswire (US)MedImmune Explores Strategic AlternativesNASDAQ:MEDIMedimmune (MM)
09/04/200723:00PR Newswire (US)MedImmune Announces Preliminary Results for 2007 First QuarterNASDAQ:MEDIMedimmune (MM)
02/04/200723:30PR Newswire (US)MedImmune Promotes Three Leaders in Key Scientific & Medical RolesNASDAQ:MEDIMedimmune (MM)
02/04/200723:15PR Newswire (US)MedImmune Announces Addition of Robert H. Hotz To Board of DirectorsNASDAQ:MEDIMedimmune (MM)
31/03/200700:31PR Newswire (US)Seven Summits Research Releases Alerts on MO, HAL, S, MEDI, and ETFCNASDAQ:MEDIMedimmune (MM)
30/03/200701:45PR Newswire (US)MedImmune Licenses Reverse Genetics Technology to sanofi pasteur for Use in Influenza Vaccine ProductionNASDAQ:MEDIMedimmune (MM)
24/03/200703:01PR Newswire (US)MedImmune Expands Anti-Interferon-Alpha Program by Initiating Phase 1 Trial in Patients With PsoriasisNASDAQ:MEDIMedimmune (MM)
 Showing the most relevant articles for your search:NASDAQ:MEDI